CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,006,089 | -16.1% | 66,228 | +3.8% | 0.55% | -11.3% |
Q2 2023 | $3,583,024 | +18.8% | 63,823 | -4.3% | 0.62% | +10.3% |
Q1 2023 | $3,016,932 | +15.1% | 66,702 | +3.5% | 0.56% | -3.3% |
Q4 2022 | $2,620,990 | -9.2% | 64,477 | +45.9% | 0.58% | -6.6% |
Q3 2022 | $2,887,000 | +5.1% | 44,182 | -2.3% | 0.62% | -6.4% |
Q2 2022 | $2,748,000 | +3.4% | 45,218 | +6.8% | 0.67% | +34.5% |
Q1 2022 | $2,657,000 | +15.7% | 42,332 | +39.7% | 0.50% | +26.5% |
Q4 2021 | $2,296,000 | +9.9% | 30,297 | +62.3% | 0.39% | +2.3% |
Q3 2021 | $2,090,000 | -30.6% | 18,668 | +0.3% | 0.38% | -32.8% |
Q2 2021 | $3,013,000 | +27.2% | 18,614 | +13.6% | 0.57% | +10.9% |
Q1 2021 | $2,369,000 | -5.1% | 16,387 | +0.5% | 0.51% | -13.8% |
Q4 2020 | $2,495,000 | +86.3% | 16,300 | +1.7% | 0.60% | +63.3% |
Q3 2020 | $1,339,000 | +39.6% | 16,020 | +22.8% | 0.36% | +29.4% |
Q2 2020 | $959,000 | +75.0% | 13,043 | +1.0% | 0.28% | +36.2% |
Q1 2020 | $548,000 | -45.6% | 12,913 | -21.9% | 0.21% | -33.4% |
Q4 2019 | $1,007,000 | +88.2% | 16,524 | +26.5% | 0.31% | +64.6% |
Q3 2019 | $535,000 | -14.1% | 13,062 | -1.3% | 0.19% | -26.5% |
Q2 2019 | $623,000 | +29.3% | 13,237 | -1.8% | 0.26% | +33.9% |
Q1 2019 | $482,000 | – | 13,485 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |